0001127602-24-010489.txt : 20240318
0001127602-24-010489.hdr.sgml : 20240318
20240318173431
ACCESSION NUMBER: 0001127602-24-010489
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240314
FILED AS OF DATE: 20240318
DATE AS OF CHANGE: 20240318
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CHAOUKI STEVEN M
CENTRAL INDEX KEY: 0001776865
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41455
FILM NUMBER: 24760261
MAIL ADDRESS:
STREET 1: C/O TRANSUNION, 555 WEST ADAMS STREET
CITY: CHICAGO
STATE: IL
ZIP: 60661
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MAIA Biotechnology, Inc.
CENTRAL INDEX KEY: 0001878313
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 444 WEST LAKE STREET, SUITE 1700
CITY: CHICAGO
STATE: IL
ZIP: 60606
BUSINESS PHONE: 312-416-8592
MAIL ADDRESS:
STREET 1: 444 WEST LAKE STREET, SUITE 1700
CITY: CHICAGO
STATE: IL
ZIP: 60606
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2024-03-14
0001878313
MAIA Biotechnology, Inc.
MAIA
0001776865
CHAOUKI STEVEN M
444 WEST LAKE STREET, SUITE 1700
CHICAGO
IL
60606
1
0
Common Stock
2024-03-14
4
P
0
34641
1.17
A
88891
D
Warrants
1.30
2024-03-14
4
P
0
34641
1.30
A
2024-09-14
2029-09-14
Common Stock
34641
34641
D
The warrants were purchased pursuant to a Securities Purchase Agreement dated March 11, 2024 and were deemed options issued under the Issuer's 2021 Equity Incentive Plan on March 14, 2024. The options are exercisable beginning on the six month anniverary of the issuance date and expire 5-years after the initial exercise date.
/s/ Steven M. Chaouki
2024-03-18